Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
SNDX
SNDX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SNDX News
Syndax Pharmaceuticals Q1 2026 Earnings Call Highlights
May 01 2026
seekingalpha
Syndax Pharmaceuticals Q1 Earnings Beat Expectations
Apr 30 2026
seekingalpha
Syndax Pharmaceuticals to Report Q1 2026 Financial Results
Apr 24 2026
Newsfilter
DAFNA Capital Reduces Stake in Syndax Pharmaceuticals
Mar 22 2026
Fool
DAFNA Capital Management Reduces SNDX Holdings
Mar 22 2026
NASDAQ.COM
Kynam Capital Management Reduces Syndax Holdings
Mar 21 2026
Fool
Kynam Capital Reduces Syndax Stake
Mar 21 2026
NASDAQ.COM
Kynam Capital Management Cuts Viridian Stake by Over $81 Million
Mar 21 2026
Yahoo Finance
Kynam Capital Reduces Stake in Cogent Biosciences by $48 Million
Mar 21 2026
Yahoo Finance
Sphera Increases Stake in Syndax Pharmaceuticals
Mar 13 2026
Fool
Sphera Funds Increases Stake in Syndax Pharmaceuticals
Mar 13 2026
NASDAQ.COM
Syndax Pharmaceuticals Grants Stock Options to New Employees
Mar 04 2026
Yahoo Finance
Syndax (SNDX) Q4 2025 Earnings Call Transcript
Feb 27 2026
NASDAQ.COM
Syndax Pharmaceuticals Q4 2025 Earnings Call Highlights
Feb 27 2026
seekingalpha
Syndax Pharma Reports Q4 Loss and Revenue Surge
Feb 27 2026
NASDAQ.COM
Syndax Pharmaceuticals Reports Q4 Earnings and 2026 Outlook
Feb 26 2026
seekingalpha
Show More News
